Key Highlights:
- Zydus has launched Aerolife Mini, a next-generation pMDI enhancer, marking a step forward in its drug-device innovation strategy in respiratory care. Introduced under an exclusive licensing deal with AeroDel Technology Innovations, Aerolife Mini is positioned as India’s first portable and foldable spacer
- The launch comes amid a rising burden of respiratory diseases such as asthma, COPD, and bronchiectasis in India, where effective inhaler use remains a challenge. With ~94% of patients reportedly making at least one critical inhalation error, conventional bulky spacers often limit portability and adherence, impacting real-world treatment outcomes
- Designed to address these gaps, Aerolife Mini features a compact, foldable, ready-to-use format aimed at improving drug deposition, reducing coordination errors, and enhancing patient compliance. By combining convenience with performance, Zydus is advancing its vision of building a differentiated, patient-centric respiratory portfolio through innovative drug-device solutions
Implications:
Aerolife Mini strengthens Zydus’ position in device-led respiratory innovation, giving it a differentiated, IP-backed spacer solution at a time when poor inhaler technique affects most Indian asthma and COPD patients.
By offering an “always-attached”, foldable, ready-to-use spacer that improves portability and drug deposition, Zydus can deepen engagement with pulmonologists and payers, potentially driving higher adherence and chronic inhaler usage across its respiratory portfolio.
Source: Zydus | Image: Zydus
